Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem, a key player in the Specialty Chemicals sector, reached a significant milestone today by hitting a new 52-week high of Rs.1603.6. This achievement marks a notable moment in the stock’s performance, reflecting sustained momentum amid a fluctuating market backdrop.

Tatva Chintan Pharma Chem, a key player in the Specialty Chemicals sector, reached a significant milestone today by hitting a new 52-week high of Rs.1603.6. This achievement marks a notable moment in the stock’s performance, reflecting sustained momentum amid a mixed market backdrop.

Tatva Chintan Pharma Chem, a key player in the Specialty Chemicals sector, reached a significant milestone today by hitting a new 52-week high of Rs.1603.6. This achievement underscores the stock's strong momentum amid a mixed market backdrop, reflecting its sustained performance over the past year.

Tatva Chintan Pharma Chem's stock has reached a new 52-week high, reflecting strong performance with consecutive gains over the past two days. The stock is trading above key moving averages and has significantly outperformed its sector and the broader market over the past month, indicating a robust position in the specialty chemicals industry.

Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong performance in the specialty chemicals sector. The stock has shown consecutive gains and remains above key moving averages, indicating a solid market position. Its one-year performance significantly surpasses that of the broader market indices.

Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong performance in the specialty chemicals sector. The stock has shown consecutive gains and remains above key moving averages, indicating resilience. Over the past year, it has significantly outperformed the broader market, highlighting its robust market position.

Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong performance in the specialty chemicals sector. The stock has shown consecutive gains and remains above key moving averages. Over the past year, it has significantly outperformed the Sensex, with notable net profit growth reported in its latest quarterly results.

Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong market momentum and a notable performance in the specialty chemicals sector. The company has outperformed its sector and reported significant growth in net profit, showcasing financial stability with a low debt-to-equity ratio.

Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting strong performance in the specialty chemicals sector. The company reported a 49.17% growth in net profit and record net sales, while maintaining a low debt-to-equity ratio, highlighting its stable financial foundation and positive market position.

Tatva Chintan Pharma Chem reached a new 52-week high today, reflecting strong performance in the specialty chemicals sector. The stock has consistently traded above key moving averages and has shown impressive gains over the past month and year, indicating robust growth and resilience in a fluctuating market.

Tatva Chintan Pharma Chem has achieved a new 52-week high, reflecting its strong performance in the specialty chemicals sector. The company reported significant net profit growth and record net sales in its latest quarterly results, while maintaining a low debt-to-equity ratio, indicating financial stability.

Tatva Chintan Pharma Chem achieved a new 52-week high of Rs. 1468.65 on November 3, 2025, reflecting strong performance in the specialty chemicals sector. The company reported impressive financial metrics, including a low debt-to-equity ratio and significant net profit growth, while trading above key moving averages.

Tatva Chintan Pharma Chem has reported strong financial results for the quarter ending September 2025, with record net sales and a peak operating profit margin. Despite low operating cash flow and a concerning debtors turnover ratio, the company has significantly outperformed the Sensex in recent weeks and year-to-date.

Tatva Chintan Pharma Chem Ltd., a speciality chemicals manufacturer, has delivered an impressive turnaround in Q2 FY26, posting a net profit of ₹9.92 crores—a remarkable 49.17% sequential jump and a recovery from the loss-making position a year ago. The ₹3,101 crore market cap company's revenue climbed 5.70% quarter-on-quarter to ₹123.52 crores, marking its highest quarterly sales ever. Following the results, the stock surged 5.71% to ₹1,433.95, trading near its 52-week high of ₹1,448.45.

Tatva Chintan Pharma Chem has achieved a new 52-week high of Rs. 1448.45, reflecting strong performance in the specialty chemicals sector. The stock demonstrated significant volatility during trading, with a notable annual gain of 66.04%, surpassing the Sensex's growth. It is also trading above key moving averages.

Tatva Chintan Pharma Chem achieved a new 52-week high of Rs. 1,423.45 on October 23, 2025, reflecting a strong annual performance. Despite a slight decline after eight consecutive days of gains, the stock remains above key moving averages, indicating a positive market trend amid a bullish overall market sentiment.